Ad is loading...
RSEBX
Price
$66.10
Change
-$0.81 (-1.21%)
Updated
Nov 15 closing price
RSLAX
Price
$57.69
Change
-$0.71 (-1.22%)
Updated
Nov 15 closing price
Ad is loading...

RSEBX vs RSLAX

Header iconRSEBX vs RSLAX Comparison
Open Charts RSEBX vs RSLAXBanner chart's image
American Funds SMALLCAP World R2E
Price$66.10
Change-$0.81 (-1.21%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World R1
Price$57.69
Change-$0.71 (-1.22%)
VolumeN/A
CapitalizationN/A
RSEBX vs RSLAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RSEBX vs. RSLAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSEBX is a Buy and RSLAX is a Buy.

FUNDAMENTALS
Fundamentals
RSEBX (74.7B) and RSLAX (74.7B) have equal amount of cash in the bank . RSLAX pays higher dividends than RSEBX: RSLAX (0.35) vs RSEBX (0.31). RSEBX was incepted earlier than RSLAX: RSEBX (10 years) vs RSLAX (22 years). RSEBX (29.00) and RSLAX (29.00) have comparable annual turnover. RSEBX (250) and RSLAX (250) have matching initial minimum investment requirements. RSEBX (15.47) and RSLAX (15.13) have marching annual gain over last year. RSEBX return over 5 years is better than : 15.94 vs. RSLAX (12.12).
RSEBXRSLAXRSEBX / RSLAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years22 years-
Gain YTD3.3463.073109%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets74.7B74.7B100%
Annual Yield % from dividends0.310.3589%
Returns for 1 year15.4715.13102%
Returns for 3 years-27.00-28.4995%
Returns for 5 years15.9412.12131%
Returns for 10 years33.3723.77140%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGC3.73-0.01
-0.27%
Canopy Growth Corp
ESS301.76-0.98
-0.32%
Essex Property Trust
TRN37.22-0.15
-0.40%
Trinity Industries
INDP1.11-0.01
-1.33%
Indaptus Therapeutics
CRBU1.99-0.10
-4.78%
Caribou Biosciences